FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903870859> ?p ?o ?g. }

• W2903870859 endingPage "458" @default.
• W2903870859 startingPage "448" @default.
• W2903870859 abstract "Abstract Inhibitors of the PD-1/PD-L1/CTLA-4 immune checkpoint pathway have revolutionized cancer treatment. Indeed, some patients with advanced, refractory malignancies achieve durable responses; however, only a subset of patients benefit, necessitating new biomarkers to predict outcome. Interrogating cell-free DNA (cfDNA) isolated from plasma (liquid biopsy) provides a promising method for monitoring response. We describe the use of low-coverage, genome-wide sequencing of cfDNA, validated extensively for noninvasive prenatal testing, to detect tumor-specific copy-number alterations, and the development of a new metric—the genome instability number (GIN)—to monitor response to these drugs. We demonstrate how the GIN can be used to discriminate clinical response from progression, differentiate progression from pseudoprogression, and identify hyperprogressive disease. Finally, we provide evidence for delayed kinetics in responses to checkpoint inhibitors relative to molecularly targeted therapies. Overall, these data demonstrate a proof of concept for using this method for monitoring treatment outcome in patients with cancer receiving immunotherapy." @default.
• W2903870859 created "2018-12-22" @default.
• W2903870859 creator A5003106584 @default.
• W2903870859 creator A5003764522 @default.
• W2903870859 creator A5009088187 @default.
• W2903870859 creator A5016103906 @default.
• W2903870859 creator A5029783882 @default.
• W2903870859 creator A5046335496 @default.
• W2903870859 creator A5046798594 @default.
• W2903870859 creator A5053481267 @default.
• W2903870859 creator A5057665768 @default.
• W2903870859 creator A5062512082 @default.
• W2903870859 creator A5073330825 @default.
• W2903870859 creator A5078229013 @default.
• W2903870859 creator A5086626483 @default.
• W2903870859 date "2019-02-01" @default.
• W2903870859 modified "2023-10-12" @default.
• W2903870859 title "Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients" @default.
• W2903870859 cites W1680591717 @default.
• W2903870859 cites W1904456416 @default.
• W2903870859 cites W1967220865 @default.
• W2903870859 cites W1983466841 @default.
• W2903870859 cites W1988290769 @default.
• W2903870859 cites W2016661249 @default.
• W2903870859 cites W2019607817 @default.
• W2903870859 cites W2049553585 @default.
• W2903870859 cites W2056785446 @default.
• W2903870859 cites W2083518637 @default.
• W2903870859 cites W2101571970 @default.
• W2903870859 cites W2108643617 @default.
• W2903870859 cites W2132238722 @default.
• W2903870859 cites W2136859769 @default.
• W2903870859 cites W2141196001 @default.
• W2903870859 cites W2171237493 @default.
• W2903870859 cites W2172268977 @default.
• W2903870859 cites W2288310435 @default.
• W2903870859 cites W2460179076 @default.
• W2903870859 cites W2463504723 @default.
• W2903870859 cites W2526207452 @default.
• W2903870859 cites W2535269087 @default.
• W2903870859 cites W2554618897 @default.
• W2903870859 cites W2574604975 @default.
• W2903870859 cites W2593030814 @default.
• W2903870859 cites W2598988196 @default.
• W2903870859 cites W2601621622 @default.
• W2903870859 cites W2605385750 @default.
• W2903870859 cites W2617224173 @default.
• W2903870859 cites W2617335484 @default.
• W2903870859 cites W2626441827 @default.
• W2903870859 cites W2747774814 @default.
• W2903870859 cites W2760825739 @default.
• W2903870859 cites W2761072972 @default.
• W2903870859 cites W2762220419 @default.
• W2903870859 cites W2889613215 @default.
• W2903870859 cites W2950811416 @default.
• W2903870859 cites W4238448376 @default.
• W2903870859 doi "https://doi.org/10.1158/1535-7163.mct-18-0535" @default.
• W2903870859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30523049" @default.
• W2903870859 hasPublicationYear "2019" @default.
• W2903870859 type Work @default.
• W2903870859 sameAs 2903870859 @default.
• W2903870859 citedByCount "58" @default.
• W2903870859 countsByYear W29038708592019 @default.
• W2903870859 countsByYear W29038708592020 @default.
• W2903870859 countsByYear W29038708592021 @default.
• W2903870859 countsByYear W29038708592022 @default.
• W2903870859 countsByYear W29038708592023 @default.
• W2903870859 crossrefType "journal-article" @default.
• W2903870859 hasAuthorship W2903870859A5003106584 @default.
• W2903870859 hasAuthorship W2903870859A5003764522 @default.
• W2903870859 hasAuthorship W2903870859A5009088187 @default.
• W2903870859 hasAuthorship W2903870859A5016103906 @default.
• W2903870859 hasAuthorship W2903870859A5029783882 @default.
• W2903870859 hasAuthorship W2903870859A5046335496 @default.
• W2903870859 hasAuthorship W2903870859A5046798594 @default.
• W2903870859 hasAuthorship W2903870859A5053481267 @default.
• W2903870859 hasAuthorship W2903870859A5057665768 @default.
• W2903870859 hasAuthorship W2903870859A5062512082 @default.
• W2903870859 hasAuthorship W2903870859A5073330825 @default.
• W2903870859 hasAuthorship W2903870859A5078229013 @default.
• W2903870859 hasAuthorship W2903870859A5086626483 @default.
• W2903870859 hasConcept C104317684 @default.
• W2903870859 hasConcept C121608353 @default.
• W2903870859 hasConcept C126322002 @default.
• W2903870859 hasConcept C141231307 @default.
• W2903870859 hasConcept C143998085 @default.
• W2903870859 hasConcept C152110520 @default.
• W2903870859 hasConcept C172680121 @default.
• W2903870859 hasConcept C2777701055 @default.
• W2903870859 hasConcept C2778258057 @default.
• W2903870859 hasConcept C2779234561 @default.
• W2903870859 hasConcept C2779529041 @default.
• W2903870859 hasConcept C54355233 @default.
• W2903870859 hasConcept C60644358 @default.
• W2903870859 hasConcept C70721500 @default.
• W2903870859 hasConcept C71924100 @default.
• W2903870859 hasConcept C86803240 @default.
• W2903870859 hasConceptScore W2903870859C104317684 @default.

• next